Statement from Kate Shaw on the passing of Her Majesty Queen Elizabeth II
Thursday 8th September 2022
It is with great sadness that we learn of the passing of Her Majesty The Queen. We join the nation in mourning a global icon who dedicated her life to her country, the Commonwealth and the wider world.
For 70 years, The Queen has been the UK’s anchor and guiding light; a beloved figurehead to millions.
The world changed immensely during her reign, but her sense of duty, stoicism and devotion to public service never wavered, not even through the darkest times. As a company, we believe a major part of her legacy is the work she did to build and strengthen ties with other countries, which contributed significantly to smooth international relations. We are in no doubt that our own success is due in no small part to her work in this area.
Our longest-reigning monarch, The Queen will live on in our hearts and the history books as a monarch who gave everything to her country. For that, we will forever be grateful.
About Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment and retention company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground” patient recruitment experts in over 70 countries, addressing individual sites’ unique recruitment and retention challenges in local language.
Innovative Trials has experience in over 25 therapeutic areas, across 90+ conditions working with some of the biggest global pharmaceuticals, Clinical Research Organizations (CROs) and biotech companies.
Innovative Trials was founded in 2010 by Kate Shaw and Dave Watkins after identifying a growing need for clinical trial patient recruitment support.
For more information, visit www.innovativetrials.com